Pharmaceutical-grade cannabinoid infusion technology.
Reimagine what’s possible
Welcome to the future of cannabis
Data backed patented technology that delivers precision and predictability to the infused product experience.
Up to 5X greater bioavailability than traditional infusion methods
Pharmaceutical-grade sophistication - Precise doses of cannabinoids and terpenes delivered in the desired ratios for a consistent, predictable, and controlled experience
Input agnostic – from full spectrum to isolate
Captures the entire extract profile – cannabinoids & terpenes
In powder form, fully water dispersible and shelf-stable
Bypasses 1st pass metabolism, delivering a higher payload into circulation
Extremely high loading capacity – with no solubility loss
Nothing comparable in the industry - not an emulsion
Clean, all natural food grade ingredients
Highlights
Faster onset
In pharma-model PK trials, DTL’s technologies consistently reached bioactivity 3-8x faster than conventional delivery methods, in as short as 5 minutes.
Superior Bioavailability
In those same studies, the ultimate concentration of cannabinoids in the blood was shown to be as much as 3x higher than conventional infusion methods.
Great Taste, Less Filler
Our solutions allow for more cannabinoids to be loaded into the final product, with minimal impacts to taste or smell, avoiding the need to overload the formulation with sugars or other masking agents.